NCT01510210View on ClinicalTrials.gov

Risk Profile for Patients With Atrial Fibrillation

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Atrial Fibrillation
Trial Locations (1)

9713 GZ Groningen

University Medical Center Groningen, Groningen

All Listed Sponsors
collaborator

Netherlands Heart Foundation

OTHER

lead

I.C. Van Gelder

OTHER

NCT01510210 - Risk Profile for Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter